CYRUSONE INC (CONE) Stock Fundamental Analysis

NASDAQ:CONE

90.36
+0.03 (+0.03%)
At close: Mar 24, 2022
90.48
+0.12 (+0.13%)
After Hours: 3/24/2022, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, CONE scores 1 out of 10 in our fundamental rating. CONE was compared to 122 industry peers in the Diversified REITs industry. CONE has a bad profitability rating. Also its financial health evaluation is rather negative. CONE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CONE had positive earnings in the past year.
CONE Yearly Net Income VS EBIT VS OCF VS FCFCONE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 0.34%
ROE 0.87%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CONE Yearly ROA, ROE, ROICCONE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -2 -4

1.3 Margins

Industry RankSector Rank
OM 4.86%
PM (TTM) 2.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CONE Yearly Profit, Operating, Gross MarginsCONE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • CONE has more shares outstanding than it did 1 year ago.
  • CONE has a better debt/assets ratio than last year.
CONE Yearly Shares OutstandingCONE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
CONE Yearly Total Debt VS Total AssetsCONE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

  • CONE has a Debt/Equity ratio of 1.25. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CONE Yearly LT Debt VS Equity VS FCFCONE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 1B -1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.71% over the past year.
  • CONE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.04% yearly.
  • The Revenue has grown by 16.66% in the past year. This is quite good.
  • CONE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.91% yearly.
EPS 1Y (TTM)5.71%
EPS 3Y-38.87%
EPS 5Y9.04%
EPS Q2Q%-26.67%
Revenue 1Y (TTM)16.66%
Revenue growth 3Y13.65%
Revenue growth 5Y17.91%
Sales Q2Q%18.63%

3.2 Future

  • Based on estimates for the next years, CONE will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.73% on average per year.
  • The Revenue is expected to grow by 7.04% on average over the next years.
EPS Next Y-51.93%
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%
EPS Next 5Y-13.73%
Revenue Next Year6.44%
Revenue Next 2Y7.57%
Revenue Next 3Y6.87%
Revenue Next 5Y7.04%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CONE Yearly Revenue VS EstimatesCONE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CONE Yearly EPS VS EstimatesCONE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 244.22, which means the current valuation is very expensive for CONE.
  • CONE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.67.
  • CONE is valuated quite expensively with a Price/Forward Earnings ratio of 508.02.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, CONE is valued quite expensively.
Industry RankSector Rank
PE 244.22
Fwd PE 508.02
CONE Price Earnings VS Forward Price EarningsCONE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400 500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.17
CONE Per share dataCONE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • A cheap valuation may be justified as CONE's earnings are expected to decrease with -16.34% in the coming years.
PEG (NY)N/A
PEG (5Y)27.01
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • CONE has a Yearly Dividend Yield of 2.30%.
  • CONE's Dividend Yield is a higher than the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

  • The dividend of CONE has a limited annual growth rate of 4.43%.
  • CONE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)4.43%
Div Incr YearsN/A
Div Non Decr YearsN/A
CONE Yearly Dividends per shareCONE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 1003.56% of the earnings are spent on dividend by CONE. This is not a sustainable payout ratio.
  • The Dividend Rate of CONE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP1003.56%
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%
CONE Yearly Income VS Free CF VS DividendCONE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 0 200M -200M -400M -600M -800M -1B
CONE Dividend Payout.CONE Dividend Payout, showing the Payout Ratio.CONE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CYRUSONE INC

NASDAQ:CONE (3/24/2022, 8:00:01 PM)

After market: 90.48 +0.12 (+0.13%)

90.36

+0.03 (+0.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-16
Earnings (Next)04-27
Inst Owners0%
Inst Owner Change0%
Ins Owners0.75%
Ins Owner Change0%
Market Cap11.85B
Revenue(TTM)1.21B
Net Income(TTM)25.30M
Analysts67.27
Price Target91.25 (0.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Yearly Dividend2.05
Dividend Growth(5Y)4.43%
DP1003.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 244.22
Fwd PE 508.02
P/S 9.83
P/FCF N/A
P/OCF N/A
P/B 4.05
P/tB N/A
EV/EBITDA 27.17
EPS(TTM)0.37
EY0.41%
EPS(NY)0.18
Fwd EY0.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.19
BVpS22.29
TBVpSN/A
PEG (NY)N/A
PEG (5Y)27.01
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.34%
ROE 0.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.86%
PM (TTM) 2.1%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.71%
EPS 3Y-38.87%
EPS 5Y9.04%
EPS Q2Q%-26.67%
EPS Next Y-51.93%
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%
EPS Next 5Y-13.73%
Revenue 1Y (TTM)16.66%
Revenue growth 3Y13.65%
Revenue growth 5Y17.91%
Sales Q2Q%18.63%
Revenue Next Year6.44%
Revenue Next 2Y7.57%
Revenue Next 3Y6.87%
Revenue Next 5Y7.04%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CYRUSONE INC / CONE FAQ

Can you provide the ChartMill fundamental rating for CYRUSONE INC?

ChartMill assigns a fundamental rating of 1 / 10 to CONE.


Can you provide the valuation status for CYRUSONE INC?

ChartMill assigns a valuation rating of 0 / 10 to CYRUSONE INC (CONE). This can be considered as Overvalued.


Can you provide the profitability details for CYRUSONE INC?

CYRUSONE INC (CONE) has a profitability rating of 1 / 10.


Can you provide the financial health for CONE stock?

The financial health rating of CYRUSONE INC (CONE) is 1 / 10.


Can you provide the expected EPS growth for CONE stock?

The Earnings per Share (EPS) of CYRUSONE INC (CONE) is expected to decline by -51.93% in the next year.